Literature DB >> 12205566

Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.

M Denton1, K Kerr, L Mooney, V Keer, A Rajgopal, K Brownlee, P Arundel, S Conway.   

Abstract

We report on an outbreak of colistin-resistant Pseudomonas aeruginosa (CRPA) that occurred in a United Kingdom pediatric cystic fibrosis (CF) unit and involved six children over a period of 5 years. All CRPA-positive children had received aerosolized colistin therapy before first isolation of resistant organisms (mean duration, 3.1 years). Four of the 6 had also received courses of intravenous colistin in the year before the first isolation of CRPA. No impact of CRPA acquisition on respiratory function, clinical condition, or radiological parameters could be demonstrated. Four of the 6 children carried isolates of CRPA indistinguishable on genotyping. Two of these 4 children were sisters. The other 2 were on the same ward together at time of first isolation, and subsequently shared overlapping admissions with one of the sisters. While there is no conclusive evidence for the route of transmission, the frequency of overlapping in-patient admissions between 3 of these patients is suggestive of patient-to-patient transfer in the nosocomial setting.CF clinicians should be aware that colistin resistance can occur in P. aeruginosa, and some of these strains are capable of spread within CF units. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205566     DOI: 10.1002/ppul.10166

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  30 in total

1.  Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.

Authors:  David Armstrong; Scott Bell; Michael Robinson; Peter Bye; Barbara Rose; Colin Harbour; Crystal Lee; Helen Service; Michael Nissen; Melanie Syrmis; Claire Wainwright
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Segregation is good for patients with cystic fibrosis.

Authors:  Steven Conway
Journal:  J R Soc Med       Date:  2008-07       Impact factor: 5.344

3.  The Essential Role of Hypermutation in Rapid Adaptation to Antibiotic Stress.

Authors:  Heer H Mehta; Amy G Prater; Kathryn Beabout; Ryan A L Elworth; Mark Karavis; Henry S Gibbons; Yousif Shamoo
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

4.  Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.

Authors:  Neang S Ly; Jenny Yang; Jurgen B Bulitta; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

5.  Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Richard J Prankerd; Ben J Boyd
Journal:  J Pharm Sci       Date:  2012-05-23       Impact factor: 3.534

6.  Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

Authors:  Samuel M Moskowitz; Elizabeth Garber; Yunhua Chen; Sarah A Clock; Setareh Tabibi; Amanda K Miller; Michael Doctor; Lisa Saiman
Journal:  J Antimicrob Chemother       Date:  2010-04-29       Impact factor: 5.790

7.  Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France.

Authors:  Poonam Sharma; Sushim Kumar Gupta; Seydina M Diene; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

8.  PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.

Authors:  Samuel M Moskowitz; Mark K Brannon; Nandini Dasgupta; Miyuki Pier; Nicole Sgambati; Amanda K Miller; Sara E Selgrade; Samuel I Miller; Miles Denton; Steven P Conway; Helle K Johansen; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

9.  Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.

Authors:  Alina D Gutu; Nicole Sgambati; Pnina Strasbourger; Mark K Brannon; Michael A Jacobs; Eric Haugen; Rajinder K Kaul; Helle Krogh Johansen; Niels Høiby; Samuel M Moskowitz
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

10.  Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  V Waters; J E A Zlosnik; Y C W Yau; D P Speert; S D Aaron; D S Guttman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-29       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.